Does OSIMERTINIB Cause Ejection fraction decreased? 102 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 102 reports of Ejection fraction decreased have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.4% of all adverse event reports for OSIMERTINIB.
102
Reports of Ejection fraction decreased with OSIMERTINIB
0.4%
of all OSIMERTINIB reports
17
Deaths
39
Hospitalizations
How Dangerous Is Ejection fraction decreased From OSIMERTINIB?
Of the 102 reports, 17 (16.7%) resulted in death, 39 (38.2%) required hospitalization, and 4 (3.9%) were considered life-threatening.
Is Ejection fraction decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OSIMERTINIB. However, 102 reports have been filed with the FAERS database.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Ejection fraction decreased?
SACUBITRIL\VALSARTAN (2,551)
TRASTUZUMAB (1,579)
DOXORUBICIN (834)
CYCLOPHOSPHAMIDE (754)
PERTUZUMAB (644)
DOCETAXEL (520)
PACLITAXEL (466)
BISOPROLOL (314)
RITUXIMAB (296)
CARVEDILOL (284)
Which OSIMERTINIB Alternatives Have Lower Ejection fraction decreased Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN